Synapse

← Global & Regional Health Technology Assessment

Papers in Global & Regional Health Technology Assessment

Page 4 · newest first

  1. Rapid Reviews with Health-Technology Assessments in Reimbursement Systems – an Examination of Ireland as a Case StudyGlobal & Regional Health Technology Assessment · 2016
  2. Cost-Effectiveness Analysis of Triptorelin versus Leuprolide in the Treatment of Advanced Prostate CancerGlobal & Regional Health Technology Assessment · 2016
  3. Therapeutic Strategies and Health Costs of Patients Admitted for a Cardiovascular Event in ItalySHILAP Revista de lepidopterología · 2016
  4. Economic evaluation of platelet-rich-plasma versus hyaluronic acid for the treatment of knee osteoarthritis. Scenarios to 1 and 5 yearsSHILAP Revista de lepidopterología · 2016
  5. Therapeutic Strategies and Health Costs of Patients Admitted for a Cardiovascular Event in ItalyGlobal & Regional Health Technology Assessment · 2016
  6. Costs of Tiotropium Bromide Delivered via the Respimat® Inhaler in COPD Patients in ItalyGlobal & Regional Health Technology Assessment · 2016
  7. Economic Evaluation of Nevirapine plus Raltegravir as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1 Infected PatientsGlobal & Regional Health Technology Assessment · 2016
  8. Economic Evaluation of Ipilimumab in First Line Treatment of Advanced Melanoma in ItalyGlobal & Regional Health Technology Assessment · 2016
  9. When Simple Becomes Complicated: Why Excel Should Lose its Place at the Top TableGlobal & Regional Health Technology Assessment · 2016
  10. Thromboprophylaxis in patients with atrial fibrillation: a real practice analysisGlobal & Regional Health Technology Assessment · 2016
  11. Thromboprophylaxis in Patients with Atrial Fibrillation: A Real Practice AnalysisGlobal & Regional Health Technology Assessment · 2016
  12. Cost-of-Illness Study of Diabetes Mellitus: Focus on Patients with Type 2 DiabetesGlobal & Regional Health Technology Assessment · 2016
  13. Therapeutic continuity in the treatment of psychiatric disordersSHILAP Revista de lepidopterología · 2015
  14. Budget impact analysis of infliximab biosimilar: the Italian scenerySHILAP Revista de lepidopterología · 2015
  15. Cost-consequence analysis of aprepitant compared to standard therapy (5-HT3 + corticosteroids) for the prevention of highly emetogenic chemotherapy-induced nausea and vomitSHILAP Revista de lepidopterología · 2015
  16. Cost-Effectiveness Analysis of Long-Acting Bronchodilators for the Treatment of COPD (Moderate to Very Severe)SHILAP Revista de lepidopterología · 2015
  17. Cost-Effectiveness Analysis of Long-Acting Bronchodilators for the Treatment of COPD (Moderate to Very Severe)Global & Regional Health Technology Assessment · 2015
  18. Economic Analysis of the Immunostimulant OM-85 for the Prevention of Paediatric Recurrent Upper Respiratory Tract InfectionsGlobal & Regional Health Technology Assessment · 2015
  19. Willingness to pay for innovation: the case of the anti-HCV drugs from the Italian National Health Service perspectiveGlobal & Regional Health Technology Assessment · 2015
  20. Therapeutic continuity in the treatment of psychiatric disordersGlobal & Regional Health Technology Assessment · 2015
  21. Budget impact analysis of infliximab biosimilar: the Italian sceneryGlobal & Regional Health Technology Assessment · 2015
  22. Cost-consequence analysis of aprepitant compared to standard therapy (5-HT 3 + corticosteroids) for the prevention of highly emetogenic chemotherapy-induced nausea and vomitGlobal & Regional Health Technology Assessment · 2015
  23. Social cost of chronic pain in ItalySHILAP Revista de lepidopterología · 2015
  24. Cost-effectiveness of ponatinib in chronic myeloid leukemia in ItalySHILAP Revista de lepidopterología · 2015
  25. Budget impact of pneumococcal vaccination in adults and elderly in ItalySHILAP Revista de lepidopterología · 2015
  26. Budget impact of pneumococcal vaccination in adults and elderly in ItalyGlobal & Regional Health Technology Assessment · 2015
  27. Social cost of chronic pain in ItalyGlobal & Regional Health Technology Assessment · 2015
  28. Cost-effectiveness of ponatinib in chronic myeloid leukemia in ItalyGlobal & Regional Health Technology Assessment · 2015
  29. Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in ItalySHILAP Revista de lepidopterología · 2014
  30. Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in ItalyGlobal & Regional Health Technology Assessment · 2014
  31. New Oncological Drugs: Analysis of Survival GainSHILAP Revista de lepidopterología · 2014
  32. Health Technology Assessment and vaccinations in ItalyGlobal & Regional Health Technology Assessment · 2014
  33. Economic Impact of Therapeutic Choices: The Case of IncretinsGlobal & Regional Health Technology Assessment · 2014
  34. Cost-Effectiveness Evaluation of Oncological Drugs Newly Marketed in ItalyGlobal & Regional Health Technology Assessment · 2014
  35. Cost-Effectiveness Studies in HIV Treatment with Lopinavir/Ritonavir: A ReviewGlobal & Regional Health Technology Assessment · 2014
  36. Cost-Effectiveness Studies in HIV Treatment with Lopinavir/Ritonavir: A ReviewSHILAP Revista de lepidopterología · 2014
  37. New Oncological Drugs: Analysis of Survival GainGlobal & Regional Health Technology Assessment · 2014